National time trend changes in psychotropic medication of child and adolescent psychiatric inpatients across Finland

Child and Adolescent Mental Health
Kim KronströmAndre Sourander

Abstract

There have been no comprehensive studies on trends in psychotropic medication use in child and adolescent inpatient settings. The aim of this nationwide study was to report changes in the psychotropic medication given to child and adolescent psychiatric inpatients across Finland and the factors associated with those changes. We asked the psychiatrist responsible for each inpatient to complete a questionnaire that included questions about the pharmacological treatment and background information. The data were collected on all inpatients on one selected study day in 2000 and 2011. Changes in the use of regular psychotropic medication were studied by comparing the data on 504 patients in 2000 and 412 patients in 2011. The study showed that there had been a significant increase in the use of psychotropic medication from 2000 to 2011. According to the multivariate analysis, the increase in psychotropic medication was associated with the study year (in 2000 39%, in 2011 58%), but could not be explained by changes in diagnostic profiles, age distribution, suicidality, violence or the Children's Global Assessment Scale scores. The use of combined psychotropic medication increased from 9% in 2000 to 25% in 2011. The increase in the use ...Continue Reading

References

May 1, 1988·Journal of the American Academy of Child and Adolescent Psychiatry·C R PfefferR Plutchik
Sep 1, 1987·Archives of General Psychiatry·H R BirdJ C Ribera
Jan 1, 1983·The American Journal of Psychiatry·C R PfefferM S Mizruchi
Nov 1, 1983·Archives of General Psychiatry·D ShafferS Aluwahlia
Jan 1, 1993·Journal of the American Academy of Child and Adolescent Psychiatry·C R PfefferC A Siefker
Jan 1, 1996·Child Psychiatry and Human Development·A SouranderJ Piha
Jul 16, 2004·European Child & Adolescent Psychiatry·Andre Sourander
Aug 14, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Evangelia M TsapakisRoss J Baldessarini
Dec 3, 2008·The American Journal of Psychiatry·Jeffrey A BridgeDavid A Brent
Feb 1, 2011·European Psychiatry : the Journal of the Association of European Psychiatrists·Y GilatG Zalsman
Mar 13, 2012·Journal of Affective Disorders·Leila Ben Amor
Nov 8, 2014·European Child & Adolescent Psychiatry·Hans-Christoph Steinhausen
Dec 17, 2014·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Stephan Collishaw
Mar 6, 2015·BMJ : British Medical Journal·Kathryn HopkinsUNKNOWN Clinical Guidelines Update Committee B
Mar 7, 2015·Journal of Psychopharmacology·Lesley Cousins, Ian M Goodyer
May 21, 2015·The New England Journal of Medicine·Mark OlfsonSteven C Marcus
Jul 2, 2015·JAMA Psychiatry·Christoph U Correll, Joseph C Blader
Jul 2, 2015·JAMA Psychiatry·Mark OlfsonMichael Schoenbaum
Sep 21, 2015·Lancet·Anita Thapar, Miriam Cooper
May 11, 2016·JAMA : the Journal of the American Medical Association·Eugenia ChanPaul G Hammerness
Jul 28, 2016·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Leslie Briars, Timothy Todd

❮ Previous
Next ❯

Citations

Feb 12, 2019·European Child & Adolescent Psychiatry·Kim KronströmAndre Sourander
Apr 29, 2018·European Child & Adolescent Psychiatry·Kaisa MishinaAndre Sourander
Jan 26, 2021·International Journal of Circumpolar Health·Anna OnnelaHanna Ebeling

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The Medical Journal of Australia
Roisin N WorsleyJayashri Kulkarni
The British Journal of Psychiatry : the Journal of Mental Science
F JohnstoneD Healy
© 2021 Meta ULC. All rights reserved